# The Swedish BioFINDER - Preclinical AD Study

> **NCT06121544** · — · RECRUITING · sponsor: **Skane University Hospital** · enrollment: 800 (estimated)

## Conditions studied

- Alzheimer Disease
- Mild Cognitive Impairment
- Mild Dementia

## Interventions

- **DIAGNOSTIC_TEST:** Plasma tau
- **DIAGNOSTIC_TEST:** Plasma β-Amyloid 42/40 (Aβ42/Aβ40)
- **DIAGNOSTIC_TEST:** Flutemetamol F18 Injection
- **DIAGNOSTIC_TEST:** [18F]-RO6958948 Injection
- **DIAGNOSTIC_TEST:** Magnetic resonance imaging (MRI)

## Key facts

- **NCT ID:** NCT06121544
- **Lead sponsor:** Skane University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-04-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2026-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06121544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06121544, "The Swedish BioFINDER - Preclinical AD Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06121544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*